scholarly journals Comparison of the Safety and Effectiveness of Four Direct Oral Anticoagulants in Japanese Patients with Nonvalvular Atrial Fibrillation Using Real-World Data

2021 ◽  
Vol 44 (9) ◽  
pp. 1294-1302
Author(s):  
Aya Enomoto ◽  
Yasunari Mano ◽  
Yohei Kawano ◽  
Tomoki Nishikawa ◽  
Takao Aoyama ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Real World ◽  
Oral Anticoagulants ◽  
Direct Oral Anticoagulants ◽  
Japanese Patients ◽  
Nonvalvular Atrial Fibrillation ◽  
Real World Data ◽  
World Data

Abstract TP519: The Effect of Different Oral Anticoagulants on Vascular Outcomes in Stroke With Atrial Fibrillation: A Real-world Data

Stroke ◽  
2019 ◽  
Vol 50 (Suppl_1) ◽  
Author(s):  
Woo-Keun Seo ◽  
Joon-Tae Kim ◽  
Jong-Won Chung ◽  
Tae-Jin Song ◽  
Yong-Jae Kim ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Real World ◽  
Oral Anticoagulants ◽  
Real World Data ◽  
World Data

Direct Oral Anticoagulants Plasma Levels Measurement: Clinical Usefulness from Trials and Real-World Data

2021 ◽  
Vol 47 (02) ◽  
pp. 150-160
Author(s):  
Francesca Renon ◽  
Anna Rago ◽  
Biagio Liccardo ◽  
Antonello D'Andrea ◽  
Lucia Riegler ◽  
...  
Keyword(s):  
Clinical Trials ◽  
Real World ◽  
Plasma Levels ◽  
Oral Anticoagulants ◽  
Direct Oral Anticoagulants ◽  
Outcome Data ◽  
Bleeding Events ◽  
Real World Data ◽  
World Data ◽  
Emergency Situations

AbstractMeasurement of direct oral anticoagulants (DOACs) activity is not routinely necessary. Indeed, evaluation of DOACs plasmatic concentration is discouraged for the majority of patients, due to the lack of outcome data supporting this approach. Nevertheless, DOAC measurements may be useful in emergency situations such as serious bleeding events, need for urgent invasive procedures, and acute ischemic stroke or in managing anticoagulation in “special populations” not adequately studied in clinical trials, for example the very elderly or those at the extremes of body weight. The aim of this review is to describe and summarize the methods for DOACs activity evaluation and the settings in which their plasma level measurement may be indicated, analyzing indications from scientific societies and evidence from clinical trials, as well as real world data on the usefulness of DOACs plasma levels “monitoring.”

scholarly journals Primary Nonadherence to Oral Anticoagulants in Patients with Atrial Fibrillation: Real-World Data from a Population-Based Cohort

2018 ◽  
Vol 24 (5) ◽  
pp. 440-448 ◽  
Author(s):  
Clara L. Rodriguez-Bernal ◽  
Salvador Peiró ◽  
Isabel Hurtado ◽  
Aníbal García-Sempere ◽  
Gabriel Sanfélix-Gimeno
Keyword(s):  
Atrial Fibrillation ◽  
Real World ◽  
Oral Anticoagulants ◽  
Population Based ◽  
Real World Data ◽  
World Data ◽  
Primary Nonadherence

Direct oral anticoagulants versus vitamin K antagonists in real-world patients with nonvalvular atrial fibrillation. The FANTASIIA study

2020 ◽  
Vol 73 (1) ◽  
pp. 14-20
Author(s):  
Manuel Anguita Sánchez ◽  
Vicente Bertomeu Martínez ◽  
Martín Ruiz Ortiz ◽  
Ángel Cequier Fillat ◽  
Inmaculada Roldán Rabadán ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Vitamin K ◽  
Real World ◽  
Vitamin K Antagonists ◽  
Oral Anticoagulants ◽  
Direct Oral Anticoagulants ◽  
Nonvalvular Atrial Fibrillation
Sign in / Sign up

Export Citation Format

Share Document